Differences in quality of life ( · children or adults with Types I or II HAE
1 finding from 1 review
Disability standardised mean difference (lower is better) (during · children or adults with Types I or II HAE
1 finding from 1 review
Adverse events(during · children or adults with Types I or II HAE
Lanadelumab showed no clear difference in adverse events(during compared with placebo or active control (low certainty).
1 finding from 1 review
Risk of HAE attacks (during · children or adults with Types I or II HAE
Berotralstat showed no clear difference in risk of HAE attacks (during compared with placebo or active control (low certainty).
1 finding from 1 review
Change in number of HAE attacks (per week) · children or adults with Types I or II HAE
1 finding from 1 review
Failure to induce clinical remission at end of study · people with active UC
Antibiotics showed no clear difference in failure to induce clinical remission at end of study compared with placebo (high certainty).
1 finding from 1 review
Failure to induce clinical response at end of study · people with active UC
It is very uncertain whether antibiotics changes failure to induce clinical response at end of study compared with 5‐ASA (very low certainty).
1 finding from 1 review
Serious adverse events · people with active UC
1 finding from 1 review
Withdrawals due to adverse events · people with active UC
1 finding from 1 review
Failure to induce clinical remission at end of study · people with active UC
It is very uncertain whether antibiotics changes failure to induce clinical remission at end of study compared with probiotics (very low certainty).
1 finding from 1 review
Failure to induce clinical response at end of study · people with active UC
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events · people with active UC
1 finding from 1 review
Withdrawals due to adverse events · people with active UC
1 finding from 1 review
Failure to induce clinical response at end of study · people with active UC
Antibiotics showed no clear difference in failure to induce clinical response at end of study compared with placebo (low certainty).
1 finding from 1 review
Failure to induce clinical remission at end of study · of active and inactive people with ulcerative colitis
It is very uncertain whether antibiotics changes failure to induce clinical remission at end of study compared with no treatment (very low certainty).
1 finding from 1 review
Failure to induce clinical response at end of study · of active and inactive people with ulcerative colitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events · of active and inactive people with ulcerative colitis
1 finding from 1 review
Withdrawals due to adverse events · of active and inactive people with ulcerative colitis
1 finding from 1 review
Serious adverse events · people with active UC
Antibiotics showed no clear difference in serious adverse events compared with placebo (low certainty).
1 finding from 1 review
Withdrawals due to adverse events · people with active UC
Antibiotics showed no clear difference in withdrawals due to adverse events compared with placebo (low certainty).
1 finding from 1 review